As new ICH GCP draft guidelines now require root cause analysis, novel methods for risk analysis and triage must be adopted in drug development.
Clara Heering
Advertisement
Articles by Clara Heering
Advertisement
Latest Updated Articles
What Errors Do We Miss in Clinical Trials?Published: March 8th 2016 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
WHO Finalizes United States’ Withdrawal from Organization: Report
2
From Evidence to Access: How Real-World Data Delivers for Patients
3
JP Morgan 2026 Wrap Up: Pharma Leaders Speak About the Conference and the State of the Industry
4
What is Daiichi Sankyo’s Post JP Morgan Strategy?
5